Major Crackdown on Production and Sale of Counterfeit E-Cigarettes

Regulations by 2FIRSTS.ai
Nov.24.2023
Major Crackdown on Production and Sale of Counterfeit E-Cigarettes
Police in Shiyan, Hubei province, China, have busted a major e-cigarette production and sales case, arresting 20 suspects and seizing over CNY 100 million worth of counterfeit products.

According to a statement released by the Dongyue Sub-bureau of the Public Security Bureau (PSB) in Shiyan, Hubei Province on November 23rd, a major case involving the production and sale of counterfeit e-cigarettes across multiple provinces and cities has been successfully cracked. The authorities have apprehended 20 suspects involved in the case, with the total value of the products involved exceeding 100 million yuan.

Major Crackdown on Production and Sale of Counterfeit E-Cigarettes
Translation: Production site of e-cigarettes. Image provided by the Shiyan police.

 

In March 2023, staff members of the Tenyan Tobacco Sales Bureau discovered the sale of fruit-flavored e-cigarettes (pods) within the urban area. They immediately launched an investigation and identified Liu as a suspect for selling tobacco products without a license. Subsequently, they reported the matter to the police.

 

After receiving a report, the Economic Investigation Brigade of Dongyue Sub-bureau proceeded to initiate a formal investigation into Liu's case. On April 20th, the specialized police officers apprehended Liu and his superior, Xiang, inside a residential property in Wuhan, where they were engaged in a transaction. A total of over 40,000 counterfeit e-cigarette pods and 136 smoking accessories were seized at the scene.

 

After the arrest of two individuals, the police successfully identified two subordinate distributors and their superior, Wu Mou, located in Wuxi, Jiangsu Province through interrogations and investigative analysis. In order to gather further evidence against Wu Mou, the specialized police team conducted on-site investigations in Wuxi. Ultimately, six suspects involved in illegal business activities, with Wu Mou as the leader, were apprehended. Additionally, three shops and three storage locations under their names were searched, resulting in the seizure of over 20,000 counterfeit e-cigarette pods and one transportation vehicle.

 

In a situation where Wu was extremely uncooperative, the investigating police analyzed and assessed the logistics and financial flows they had already obtained. As the evidence chain became clearer, Wu's psychological defenses were gradually breached, and he confessed to the process of contacting Feng and Qiu to obtain goods.

 

As a result, the task force immediately traveled to Dongguan to carry out an investigation, successfully identifying several suspected criminals, including Feng and Qiu. However, no finished fruit-flavored e-cigarette (pod) products were found at the production site. After more than two months of investigation, the police gradually unraveled information regarding the organization structure and production patterns of the criminal gang.

 

On July 26th, under the careful coordination of the public security authorities and tobacco department in multiple locations, the special task force of the Dongyue Sub-bureau and staff from the tobacco department carried out simultaneous operations in Dongguan, Zhongshan, and Zhanjiang, Guangdong. They successfully arrested two suspects involved in the case, dismantled three e-cigarette manufacturing sites, and shut down two storage and distribution centers. This operation effectively disrupted the entire supply chain of e-cigarette production, sales, and raw material processing related to this case.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

France Bans Zyn and Other Nicotine Pouches, Violators Face Jail and Fines
France Bans Zyn and Other Nicotine Pouches, Violators Face Jail and Fines
France has officially banned nicotine pouches and other oral nicotine products, including Zyn. The new regulation classifies such products as “toxic substances” and imposes criminal penalties on their use, possession, purchase, and sale. Violators may face up to five years in prison and fines of up to €400,000 (approximately $436,600).
Regulations
May.25
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13
Vuse Alto Adds New U.S. Price Tier as BAT Pushes Deeper Into Mass-Market Vaping
Vuse Alto Adds New U.S. Price Tier as BAT Pushes Deeper Into Mass-Market Vaping
British American Tobacco (BAT) subsidiary Vuse Alto has recently adjusted its price tiers in U.S. convenience store channels, leveraging low-cost device kits and pod promotions to reinforce its positioning in the mid-priced closed-system e-cigarette market.
Jun.17
Fifth Circuit Hears Challenge to FDA’s Standard for Reviewing Flavored Vape Applications
Fifth Circuit Hears Challenge to FDA’s Standard for Reviewing Flavored Vape Applications
A three-judge panel of the U.S. Court of Appeals for the Fifth Circuit heard oral arguments on Tuesday in a case brought by seven small vape-liquid companies challenging the Food and Drug Administration’s denial of marketing authorization for their flavored electronic nicotine products.
Apr.30 by 2FIRSTS.ai
Capital Group Takes 5.61% Stake in KT&G, Joining Major Foreign Shareholders
Capital Group Takes 5.61% Stake in KT&G, Joining Major Foreign Shareholders
KT&G disclosed in a regulatory filing on Friday that Capital Research and Management Company, the investment management arm of Capital Group, had acquired a 5.61% stake through purchases made on April 22 and May 4. The move places Capital Group among KT&G’s prominent foreign shareholders, alongside BlackRock, First Eagle Investment Management and Singapore’s sovereign wealth fund GIC.
May.08 by 2FIRSTS.ai
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13